400 related articles for article (PubMed ID: 26417084)
21. Single-molecule analysis of phospholipid scrambling by TMEM16F.
Watanabe R; Sakuragi T; Noji H; Nagata S
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3066-3071. PubMed ID: 29507235
[TBL] [Abstract][Full Text] [Related]
22. Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.
Kuijpers MJ; Munnix IC; Cosemans JM; Vlijmen BV; Reutelingsperger CP; Egbrink MO; Heemskerk JW
Microcirculation; 2008 May; 15(4):269-82. PubMed ID: 18464157
[TBL] [Abstract][Full Text] [Related]
23. Exposure of phosphatidylserine on the cell surface.
Nagata S; Suzuki J; Segawa K; Fujii T
Cell Death Differ; 2016 Jun; 23(6):952-61. PubMed ID: 26891692
[TBL] [Abstract][Full Text] [Related]
24. Regulation of TMEM16A/ANO1 and TMEM16F/ANO6 ion currents and phospholipid scrambling by Ca
Schreiber R; Ousingsawat J; Wanitchakool P; Sirianant L; Benedetto R; Reiss K; Kunzelmann K
J Physiol; 2018 Jan; 596(2):217-229. PubMed ID: 29134661
[TBL] [Abstract][Full Text] [Related]
25. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
[TBL] [Abstract][Full Text] [Related]
26. Hyperuricemia enhances procoagulant activity of vascular endothelial cells through TMEM16F regulated phosphatidylserine exposure and microparticle release.
Yu H; Wang Z; Li Z; An Y; Yan M; Ji S; Xu M; Wang L; Dong W; Shi J; Gao C
FASEB J; 2021 Sep; 35(9):e21808. PubMed ID: 34390515
[TBL] [Abstract][Full Text] [Related]
27. Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity.
Leung R; Gwozdz AM; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
J Thromb Haemost; 2007 Mar; 5(3):560-70. PubMed ID: 17155950
[TBL] [Abstract][Full Text] [Related]
28. Glycoprotein IIb/IIIa blockade inhibits platelet aminophospholipid exposure by potentiating translocase and attenuating scramblase activity.
Razmara M; Hu H; Masquelier M; Li N
Cell Mol Life Sci; 2007 Apr; 64(7-8):999-1008. PubMed ID: 17372676
[TBL] [Abstract][Full Text] [Related]
29. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
Somajo S; Koshiar RL; Norström E; Dahlbäck B
Thromb Res; 2014 Jul; 134(1):144-52. PubMed ID: 24835672
[TBL] [Abstract][Full Text] [Related]
30. Ion channel and lipid scramblase activity associated with expression of TMEM16F/ANO6 isoforms.
Scudieri P; Caci E; Venturini A; Sondo E; Pianigiani G; Marchetti C; Ravazzolo R; Pagani F; Galietta LJ
J Physiol; 2015 Sep; 593(17):3829-48. PubMed ID: 26108457
[TBL] [Abstract][Full Text] [Related]
31. Calpain inhibition by calpeptin does not prevent APLT activity reduction in PS-exposing platelets, but calpeptin has independent pro-apoptotic effects.
Gwozdz AM; Leung R; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
Thromb Haemost; 2010 Jun; 103(6):1218-27. PubMed ID: 20352156
[TBL] [Abstract][Full Text] [Related]
32. Selective serotonin reuptake inhibitors facilitate ANO6 (TMEM16F) current activation and phosphatidylserine exposure.
Kim HJ; Jun I; Yoon JS; Jung J; Kim YK; Kim WK; Kim BJ; Song J; Kim SJ; Nam JH; Lee MG
Pflugers Arch; 2015 Nov; 467(11):2243-56. PubMed ID: 25630304
[TBL] [Abstract][Full Text] [Related]
33. TMEM16E regulates endothelial cell procoagulant activity and thrombosis.
Schmaier AA; Anderson PF; Chen SM; El-Darzi E; Aivasovsky I; Kaushik MP; Sack KD; Hartzell HC; Parikh SM; Flaumenhaft R; Schulman S
J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 36951953
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the scrambling domain of the TMEM16 family.
Gyobu S; Ishihara K; Suzuki J; Segawa K; Nagata S
Proc Natl Acad Sci U S A; 2017 Jun; 114(24):6274-6279. PubMed ID: 28559311
[TBL] [Abstract][Full Text] [Related]
35. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction.
Wolfs JL; Comfurius P; Rasmussen JT; Keuren JF; Lindhout T; Zwaal RF; Bevers EM
Cell Mol Life Sci; 2005 Jul; 62(13):1514-25. PubMed ID: 15971000
[TBL] [Abstract][Full Text] [Related]
36. Procoagulant expression in platelets and defects leading to clinical disorders.
Solum NO
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2841-6. PubMed ID: 10591659
[TBL] [Abstract][Full Text] [Related]
37. A role for platelet TRPC channels in the Ca2+ response that induces procoagulant activity.
Mahaut-Smith MP
Sci Signal; 2013 Jun; 6(281):pe23. PubMed ID: 23800467
[TBL] [Abstract][Full Text] [Related]
38. Absence of platelet-dependent fibrin formation in a patient with Scott syndrome.
Wielders SJ; Broers J; ten Cate H; Collins PW; Bevers EM; Lindhout T
Thromb Haemost; 2009 Jul; 102(1):76-82. PubMed ID: 19572071
[TBL] [Abstract][Full Text] [Related]
39. Platelet-derived microparticles regulates thrombin generation via phophatidylserine in abdominal sepsis.
Wang Y; Zhang S; Luo L; Norström E; Braun OÖ; Mörgelin M; Thorlacius H
J Cell Physiol; 2018 Feb; 233(2):1051-1060. PubMed ID: 28409836
[TBL] [Abstract][Full Text] [Related]
40. Chemically induced vesiculation as a platform for studying TMEM16F activity.
Han TW; Ye W; Bethel NP; Zubia M; Kim A; Li KH; Burlingame AL; Grabe M; Jan YN; Jan LY
Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1309-1318. PubMed ID: 30622179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
